HLA Haplotype Mismatch Transplants and Posttransplant Cyclophosphamide

Item

http://www.wikidata.org/entity/Q26752908

description

2016 nî lūn-bûn

@nan

2016 թուականին հրատարակուած գիտական յօդուած

@hyw

2016 թվականին հրատարակված գիտական հոդված

@hy

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

name

HLA Haplotype Mismatch Transplants and Posttransplant Cyclophosphamide

@ast

HLA Haplotype Mismatch Transplants and Posttransplant Cyclophosphamide

@en

HLA Haplotype Mismatch Transplants and Posttransplant Cyclophosphamide

@nl

type

Item

label

HLA Haplotype Mismatch Transplants and Posttransplant Cyclophosphamide

@ast

HLA Haplotype Mismatch Transplants and Posttransplant Cyclophosphamide

@en

HLA Haplotype Mismatch Transplants and Posttransplant Cyclophosphamide

@nl

prefLabel

HLA Haplotype Mismatch Transplants and Posttransplant Cyclophosphamide

@ast

HLA Haplotype Mismatch Transplants and Posttransplant Cyclophosphamide

@en

HLA Haplotype Mismatch Transplants and Posttransplant Cyclophosphamide

@nl

P1476

HLA Haplotype Mismatch Transplants and Posttransplant Cyclophosphamide

@en

P2093

Andrea Bacigalupo

http://www.w3.org/2001/XMLSchema#string

Simona Sica

http://www.w3.org/2001/XMLSchema#string

P2860

Hematopoietic stem cell transplantation donor sources in the 21st century: choosing the ideal donor when a perfect match does not exist

T-cell-replete haploidentical HSCT with low-dose anti-T-lymphocyte globulin compared with matched sibling HSCT and unrelated HSCT

Hematopoietic SCT in Europe 2013: recent trends in the use of alternative donors showing more haploidentical donors but fewer cord blood transplants.

Risk-stratified outcomes of nonmyeloablative HLA-haploidentical BMT with high-dose posttransplantation cyclophosphamide.

Haploidentical transplant with posttransplant cyclophosphamide vs matched unrelated donor transplant for acute myeloid leukemia.

HLA-haploidentical bone marrow transplantation with posttransplant cyclophosphamide expands the donor pool for patients with sickle cell disease.

Negative depletion of α/β+ T cells and of CD19+ B lymphocytes: a novel frontier to optimize the effect of innate immunity in HLA-mismatched hematopoietic stem cell transplantation.

Unmanipulated haploidentical bone marrow transplantation and post-transplant cyclophosphamide for hematologic malignanices following a myeloablative conditioning: an update.

P304

7802967

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

review article

P3181

2421524

http://www.w3.org/2001/XMLSchema#string

P356

10.1155/2016/7802967

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

2016

http://www.w3.org/2001/XMLSchema#string

P577

2016-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27143973

http://www.w3.org/2001/XMLSchema#string

P932

4838781

http://www.w3.org/2001/XMLSchema#string